BCHE and Alzheimer disease: Sex-related differences in the responses of AD patients to cholinesterase inhibitors have been reported but data are limited with few studies explicitly analyzing the impact of sex on treatment outcomes as pointed out in recent reviews (Canevelli et al., 2017; Mehta et al., 2017).